Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The changing model.

Cranio : the journal of craniomandibular practice·2014
Same author

Dr. Spahl's open letter to the editor of the American journal of orthodontics and dentofacial orthopedics.

Cranio : the journal of craniomandibular practice·2013
Same author

Dr. Spahl comments on Dr. Dennis Brenkert's article in the July 2010 issue of CRANIO.

Cranio : the journal of craniomandibular practice·2010
Same author

Chronic pain.

Journal of the American Dental Association (1939)·2009
Same author

TMJ class warfare.

Cranio : the journal of craniomandibular practice·2009
Same author

More about TMD.

Journal of the American Dental Association (1939)·2007
Same journal

Functional and patient-reported outcomes of 3-dimensional-printed vs conventionally fabricated complete dentures: A randomized crossover clinical trial.

Journal of the American Dental Association (1939)·2026
Same journal

Interradicular multilocular radiolucency of the anterior mandible.

Journal of the American Dental Association (1939)·2026
Same journal

Dental manifestations of rare skeletal disorders: Diagnosis and treatment for the oral health care provider.

Journal of the American Dental Association (1939)·2026
Same journal

Beyond risk of bias: Strengthening systematic reviews in dentistry through structured trustworthiness assessment of randomized controlled trials.

Journal of the American Dental Association (1939)·2026
Same journal

Severity and financial outcomes associated with dental diagnostic errors in paid malpractice claims in the United States from 2004 through 2021.

Journal of the American Dental Association (1939)·2026
Same journal

Glycated hemoglobin levels in participants with diabetes and oral disease enrolled in the All of Us Research Program.

Journal of the American Dental Association (1939)·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

More thoughts on TMD

Terrance J Spahl

    Journal of the American Dental Association (1939)
    |June 4, 2008
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System
    12:19

    Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System

    Published on: January 20, 2012

    Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
    11:17

    Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

    Published on: November 25, 2025

    Related Experiment Videos

    Last Updated: Jul 4, 2026

    Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
    13:20

    Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

    Published on: December 5, 2025

    Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System
    12:19

    Utilizing Transcranial Magnetic Stimulation to Study the Human Neuromuscular System

    Published on: January 20, 2012

    Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
    11:17

    Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

    Published on: November 25, 2025